4//SEC Filing
Mahal Jeetinder Singh 4
Accession 0001213900-24-015462
CIK 0001788028other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 7:31 PM ET
Size
5.7 KB
Accession
0001213900-24-015462
Insider Transaction Report
Form 4
Mahal Jeetinder Singh
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-15+40,000→ 40,000 totalExercise: $17.95Exp: 2034-02-15→ Voting Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001882877
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 7:31 PM ET
- Size
- 5.7 KB